Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...
The Pfizer/BioNTech bivalent COVID-19 vaccine (Original and Omicron BA.4/BA.5) has the FDA’s EUA for use in individuals 5 years and over as a single booster dose administered at least two ...
The UK Government has recommended offering a COVID-19 booster vaccination in autumn, 2024, to individuals at high risk of ...
There are three different COVID vaccines to choose from this season: two mRNA vaccines from Pfizer and Moderna, and a ...
Stay informed with the latest news on COVID-19 and vaccines from the editors at U.S. News. (Braulio Jatar|SOPA Images (Braulio Jatar|SOPA Images Despite a summer surge, the disease that's killed ...
Barely three years ago, Pfizer was the toast of the pharmaceutical world and Bourla, who was elevated to the top job in 2019, wrote a book about the race to develop the coronavirus vaccine.
COVID-19 2024–2025 vaccines are recommended for everyone aged 6 months and older, with vaccines targeting the JN.1 and KP.2 strains of SARS-CoV-2.
Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...
GlobalData on MSN1d
FDA expands Pfizer’s RSV vaccine label to include all high-risk adultsThe US Food and Drug Administration (FDA) has expanded the indication for Pfizer’s respiratory syncytial virus (RSV) vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback